Jiao Wu
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correspondence to editorial on "CD36 Promotes iron accumulation and dysfunction in CD8+ T cells via the p38-CEBPB-TfR1 axis in early-stage hepatocellular carcinoma".
Journal: Clinical and molecular hepatology
Published: April 11, 2025
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin.
Journal: Frontiers in immunology
Published: November 21, 2024
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 17, 2024
IGF2BP1 Promotes the Liver Cancer Stem Cell Phenotype by Regulating MGAT5 mRNA Stability by m6A RNA Methylation.
Journal: Stem cells and development
Published: September 13, 2021
Oncogenic Activation of YAP Signaling Sensitizes Ferroptosis of Hepatocellular Carcinoma via ALOXE3-Mediated Lipid Peroxidation Accumulation.
Journal: Frontiers in cell and developmental biology
Published: August 01, 2021
Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export.
Journal: Cell metabolism
Published: February 15, 2020
ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma.
Journal: Experimental cell research
Published: May 31, 2018
Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.
Journal: Hepatology (Baltimore, Md.)
Published: September 12, 2017
HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
Journal: Molecular cancer therapeutics
Published: December 24, 2014
Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Journal: Journal of molecular histology
Published: September 25, 2014
Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation.
Journal: Journal of the National Cancer Institute
Published: September 12, 2014
Last Updated: 09/26/2026